# Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

> **NCT03038594** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 13 (actual)

## Conditions studied

- Burns
- Growth Hormone Treatment

## Interventions

- **DRUG:** Somatropin
- **DRUG:** 0.09% Saline Solution

## Key facts

- **NCT ID:** NCT03038594
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2021-11-02
- **Final completion:** 2021-11-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038594, "Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03038594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*